Full Press Release Details
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
Company to Scale and Optimize Global Category-Led, Market Activation Growth Model
Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position
of EVP & Chief Commercial Officer to Lead Global Market Activation
Triona Schmelter, EVP & President Consumer Self-Care Americas (CSCA), to Leave Organization
July 1, 2025 Dublin, Ireland Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today
announced that it is scaling and optimizing its proven growth model anchored in global Category Leadership and Market Activation across the organization to enhance agility, accelerate innovation, and drive long-term sustainable growth.
This organizational alignment advances Perrigo s multi-year Stabilize, Streamline and Strengthen ( Three-S ) plan and reflects operational readiness across the Company.
This is an important next step forward for Perrigo, said Patrick Lockwood-Taylor, President and CEO. By aligning our organization
around global categories and empowering market activation, we are positioning Perrigo to drive long-term performance with deeper customer and consumer engagement. This move links the organization to our strategy of scaling more molecules, more
efficiently, to more consumers across more markets. This alignment is not just about structure it s about performance, purpose and unlocking the full potential of our people and our portfolio.
Key Highlights of Our Category-Led, Market Activation Growth Model:
As part of this alignment, the roles of EVP and President CSCI and EVP and President CSCA will be
discontinued. Triona Schmelter will depart the organization and be available on a consultative basis until October 31, 2025. Perrigo extends its sincere gratitude for her leadership and contributions over the past two years, including the
launch of Opill which was a significant inflection point for CSCA and women s reproductive health in the U.S.
I want to recognize Triona s contributions in navigating the complexities of the infant formula market and strengthening our store brand position.
We wish her all the best in her future endeavors, added Lockwood-Taylor.
This alignment will follow all applicable information and consultation
processes, as legally required, and is expected to be implemented over the coming months.
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to
consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used
without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms and value tiers.
unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill , Mederma , Compeed , EllaOne , and Jungle Formula .
For more information, visit www.perrigo.com.
Forward-Looking Statements
includes, and the matters discussed in Perrigo s upcoming earnings release will include certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking
statements involve known and unknown risks, uncertainties and other factors many of which are beyond the Company s control that may cause the actual results, performance or achievements of the Company to be materially different from
its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company s filings with the United States Securities and Exchange Commission, available at
https://investor.perrigo.com/sec-filings, for a discussion of the Company s business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto,
including those discussed under Risk Factors in the Company s Form 10-K for the year ended December 31, 2024.
Bradley Joseph, Vice President,